创伤后应激障碍诊断与治疗的最新进展

S. Dowd, P. Janicak
{"title":"创伤后应激障碍诊断与治疗的最新进展","authors":"S. Dowd, P. Janicak","doi":"10.1097/01.IDT.0000325061.73022.3c","DOIUrl":null,"url":null,"abstract":"Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000325061.73022.3c","citationCount":"2","resultStr":"{\"title\":\"An Update on Diagnostic and Treatment Issues in the Management of Post‐Traumatic Stress Disorder\",\"authors\":\"S. Dowd, P. Janicak\",\"doi\":\"10.1097/01.IDT.0000325061.73022.3c\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.\",\"PeriodicalId\":90307,\"journal\":{\"name\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/01.IDT.0000325061.73022.3c\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.IDT.0000325061.73022.3c\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000325061.73022.3c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

Dowd博士透露,她曾获得Astra-Zeneca和bristol - myers Squibb的资助/研究支持;曾经/现在获得了杨森、Neuronetics、赛诺菲-安万特和索尔维的资助/研究支持;他是Neuronetics的顾问。Janicak博士透露,他曾获得Astra-Zeneca和bristol - myers Squibb的研究资助;曾获得杨森、Neuronetics、赛诺菲-安万特和索尔维的研究资助;曾经/现在是Astra-Zeneca, bristol myers Squibb, Janssen, Neuronetics和Solvay的顾问/顾问;曾是雅培、阿斯特拉-利康、百时美施贵宝和辉瑞公司演讲局的成员。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An Update on Diagnostic and Treatment Issues in the Management of Post‐Traumatic Stress Disorder
Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Treatment of Chronic Pain With Psychotropic Medications Psychopharmacologic Treatments for Alzheimer Disease and Related Dementias Transcranial Direct Current Stimulation for the Treatment of Major Depression Beta-Blockers: Off-Label Use in Psychiatric Disorders Novel Approaches for Managing Schizophrenia: Part I
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1